Cargando…

Reversible Hypokalemia and Bartter-Like Syndrome during Prolonged Systemic Therapy with Colistimethate Sodium in an Adult Patient

We present the case of a 58-year-old woman who developed hypokalaemia and metabolic alkalosis 2 weeks after therapy with colistimethate sodium for the treatment of chronic lower limb ulcer infection by extensively drug-resistant (XDR) Pseudomonas aeruginosa. The metabolic changes observed resembled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamal Eldin, Tarek, Tosone, Grazia, Capuano, Alfredo, Orlando, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505885/ https://www.ncbi.nlm.nih.gov/pubmed/28699114 http://dx.doi.org/10.1007/s40800-017-0052-1

Ejemplares similares

Acquired Bartter-like Syndrome Presenting with Polyuria and Reversible Hypokalemia Associated with Colistin Use in a Critically Ill Pediatric Patient
por: Yavas, Damla P, et al.
Publicado: (2021)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
por: Uttley, Lesley, et al.
Publicado: (2013)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
por: Bamgbola, Oluwatoyin Fatai, et al.
Publicado: (2021)

Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes
por: Bamgbola, Oluwatoyin Fatai, et al.
Publicado: (2020)

A Novel Validated Injectable Colistimethate Sodium Analysis Combining Advanced Chemometrics and Design of Experiments
por: Dagla, Ioanna, et al.
Publicado: (2021)

Colistin-induced Bartter-like Syndrome: Ponder before Treatment!
por: Kumari, Anju, et al.
Publicado: (2022)

Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium
por: Collie, David, et al.
Publicado: (2015)

Adverse Events and Drug Resistance in Critically Ill Patients Treated with Colistimethate Sodium: A Review of the Literature
por: Ahumada Topete, Victor Hugo, et al.
Publicado: (2023)

Interaction of Bacterial Phenazines with Colistimethate in Bronchial Epithelial Cells
por: Mossine, Valeri V., et al.
Publicado: (2018)

Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2014)

Neutrophil Gelatinase-associated Lipocalin as a Predictor of Acute Kidney Injury in Patients during Treatment with Colistimethate Sodium
por: Park, So Yeon, et al.
Publicado: (2018)

Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections
por: Sadyrbaeva-Dolgova, Svetlana, et al.
Publicado: (2022)

Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
por: de la Rosa-Carrillo, David, et al.
Publicado: (2022)

A Patient with Cystinosis Presenting Like Bartter Syndrome and Review of Literature
por: Ertan, Pelin, et al.
Publicado: (2012)

2559. Antibiotic-induced Bartter-like syndrome - A Systematic Review
por: Priyadarshi, Megha, et al.
Publicado: (2023)

Cystinosis Presenting with Findings of Bartter Syndrome
por: Özkan, Behzat, et al.
Publicado: (2011)

Antenatal Bartter Syndrome: A Review
por: Bhat, Y. Ramesh, et al.
Publicado: (2012)

Anaesthesia for laparoscopic cholecystectomy in Bartter’s syndrome
por: Bhaskar, Bala S, et al.
Publicado: (2010)

Antenatal Bartter's syndrome with sensorineural deafness
por: Bhamkar, R. P., et al.
Publicado: (2009)

Bartter's syndrome in a geriatric patient
por: Kumar, A. C. V., et al.
Publicado: (2016)

Bartter syndrome: causes, diagnosis, and treatment
por: Cunha, Tamara da Silva, et al.
Publicado: (2018)

Association of Amelogenesis Imperfecta and Bartter's Syndrome
por: Kumar, A. C. V., et al.
Publicado: (2017)

Bartter and Gitelman syndromes: Questions of class
por: Besouw, Martine T. P., et al.
Publicado: (2019)

Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects
por: Seyberth, Hannsjörg W., et al.
Publicado: (2011)

Bartter syndrome-like phenotype in a patient with diabetes: a case report
por: Dalugama, Chamara, et al.
Publicado: (2018)

Childhood Bartter’s syndrome: An Indian case series
por: Sampathkumar, K., et al.
Publicado: (2010)

Nephrocalcinosis and Placental Findings in Neonatal Bartter Syndrome
por: Maruyama, Hidehiko, et al.
Publicado: (2012)

A Case of Adult-Onset Bartter’s Syndrome
por: Park, Jong Wook, et al.
Publicado: (1995)

Acquired Bartter syndrome following gentamicin therapy
por: Singh, J., et al.
Publicado: (2016)

Clinical and diagnostic features of Bartter and Gitelman syndromes
por: Walsh, Patrick R, et al.
Publicado: (2018)

Late-onset Bartter syndrome type II
por: Gollasch, Benjamin, et al.
Publicado: (2017)

Mutation spectrum of Chinese patients with Bartter syndrome
por: Han, Yue, et al.
Publicado: (2017)

Pseudo‐Bartter syndrome in children with cystic fibrosis
por: Faraji‐Goodarzi, Mojgan
Publicado: (2019)

Bartter Syndrome: Perspectives of a Pediatric Nephrologist
por: Choi, Naye, et al.
Publicado: (2022)

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
por: Greenwood, James, et al.
Publicado: (2017)

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
por: Schuster, Antje, et al.
Publicado: (2013)

Colistin-induced Acquired Bartter-like Syndrome: A Rare Cause of Difficult Weaning
por: Mahendran, AJ, et al.
Publicado: (2020)

Bartter-Like Syndrome as the Initial Presentation of Dent Disease 1: A Case Report
por: Chen, Qiaoping, et al.
Publicado: (2021)

N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions
por: Ceylan, Bahadir, et al.
Publicado: (2018)

Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections
por: Kyriakoudi, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3jlndf3t8jsa5jhg485hrr9eqt